Search for: "TEVA Pharmaceuticals USA, Inc."
Results 101 - 120
of 482
Sort by Relevance
|
Sort by Date
4 Dec 2018, 11:16 am
Teva Pharmaceuticals USA Inc. is also available. [read post]
2 Dec 2018, 9:00 am
Teva Pharmaceuticals USA Inc. [read post]
27 Nov 2018, 9:30 am
Teva Pharmaceuticals USA Inc. presents the next one of those cases. [read post]
23 Nov 2018, 8:03 pm
Teva Pharmaceuticals USA Inc. case beginning at 4:00 pm (Eastern) on December 4, 2018 at the American University Washington College of Law in Washington, DC. [read post]
17 Oct 2018, 7:49 pm
The Federal Circuit found the district court committed no error in construing claim terms as non-limiting for nonobviousness purposes or in invalidating as obvious all asserted claims of the Copaxone patents, including a 40-milligram dosage three times per week (Teva Pharmaceuticals USA, Inc. v. [read post]
15 Oct 2018, 7:05 am
This week the Court released the calendar for arguments at the end of November and into December these cases are: Apple, Inc. v. [read post]
12 Oct 2018, 1:24 pm
Delaware of invalidity of claims:Plaintiffs-Appellants Teva Pharmaceuticals USA,Inc., Teva Pharmaceutical Industries, Ltd., Teva Neuroscience,Inc., and Yeda Research and Development Co. [read post]
24 Sep 2018, 1:08 pm
New Prime Inc. v. [read post]
17 Sep 2018, 6:48 am
(Torrent), Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis), and Torrent Pharmaceuticals Limited. [read post]
10 Sep 2018, 10:17 am
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
26 Aug 2018, 4:35 am
Teva Pharmaceuticals USA Inc., on appeal from the Federal Circuit. [read post]
26 Aug 2018, 4:35 am
Teva Pharmaceuticals USA Inc., on appeal from the Federal Circuit. [read post]
8 Aug 2018, 1:51 pm
The current Supreme Court is friendly toward big business. [read post]
23 Jul 2018, 2:38 pm
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
23 Jul 2018, 12:05 pm
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229. [read post]
22 Jul 2018, 8:32 pm
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc. and Akorn, Inc., which had... [read post]
18 Jul 2018, 11:23 am
Teva Pharmaceuticals USA, Inc., a case with broad implications for the pharmaceutical industry. [read post]
13 Jul 2018, 5:48 pm
Teva Pharmaceuticals USA, Inc., is apertinent intervening case, but did not explain how it isan intervening change in law to the inherency doctrine,especially given that it is an on-sale bar case. 855 F.3d1356 (Fed. [read post]
5 Jul 2018, 7:20 am
Teva Pharmaceuticals, USA, Inc., 429 F.3d 1364 (Fed. [read post]
5 Jul 2018, 7:20 am
Teva Pharmaceuticals, USA, Inc., 429 F.3d 1364 (Fed. [read post]